MA

Mark Adams

Co-Founder, Chairman and Chief Executive Officer

Direct Biologics

Direct Biologics Pipeline

DrugIndicationPhase
ExoFlo™All-Cause Acute Respiratory Distress Syndrome (ARDS)Phase 3